Highly effective delivery of medication is possible in home use with improved breath-actuated nebulizer (BAN) driven by home compressor

J. Malpass, M. Nagel, V. Avvakoumova, H. MacKay, C. Doyle, J. Mitchell (London, Canada)

Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Session: Drug delivery and pharmacokinetics II
Session type: Thematic Poster Session
Number: 4548

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Malpass, M. Nagel, V. Avvakoumova, H. MacKay, C. Doyle, J. Mitchell (London, Canada). Highly effective delivery of medication is possible in home use with improved breath-actuated nebulizer (BAN) driven by home compressor. Eur Respir J 2010; 36: Suppl. 54, 4548

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
GENebu project, home nebulizer use and maintenance in Italy
Source: Eur Respir J 2001; 18: Suppl. 33, 116s
Year: 2001

Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003

A breath-actuated jet nebulizer (BAN) has dosimetric capability for a suspension formulation based on differing volume fill of medication as well as run time
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010


A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 1: Table-top compressors
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012


Oxygen prescription, monitoring and use as a nebuliser driving gas
Source: Eur Respir J 2006; 28: Suppl. 50, 53s
Year: 2006

Comparison of aerosol delivery from two inhaler technique-guidance devices.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI)
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014

Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
Source: ERJ Open Res, 7 (4) 00463-2021; 10.1183/23120541.00463-2021
Year: 2021



GENebu Project: home nebulizer use and maintenance in Italy
Source: Eur Respir J 2001; 18: 758-763
Year: 2001



The delivery of placebo measles vaccine by a mechanically-operated breath-actuated nebulizer (BAN)
Source: Eur Respir J 2006; 28: Suppl. 50, 456s
Year: 2006

Breath activated inhaler usage and impact on rescue medication usage in patients with an asthma diagnosis: a prescribing claims study of 2823 patients using a CFC - pMDI and a breath-actuated device
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Evaluation of the technique of use of inhaler devices by patients at home through a video mobile application: A pilot study
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Is a more frequent use of small volume nebulizer aerosol during hospitalisation by respiratory nurses a guarantee for better adherence to aerosol guidelines?
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010

Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012